Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation

Carcinogenesis

Volumn 20, Issue 11, 1999, Pages 2137-2142

  Kramer Stickland, Kim ^a   Edmonds, Andrew ^a   Bair III, Warner B ^a   Bowden, G Tim ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; FERRIC CHLORIDE; TRANSCRIPTION FACTOR AP 1; TROLOX C;

ARTICLE; CELL LINE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; TRANSACTIVATION; ULTRAVIOLET B RADIATION;

ANTIOXIDANTS; CELL LINE; DEFEROXAMINE; FERRIC COMPOUNDS; HUMANS; IRON CHELATING AGENTS; REACTIVE OXYGEN SPECIES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

EID: 0032724265     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.11.2137     Document Type: Article

References (70)

1. Richardson, D.R. and Ponka, P. (1998) Development of iron chelators to treat iron overload disease and their use as experimental tools to probe intracellular iron metabolism. Am. J. Hematol., 58, 299-305.
2. Reizenstein, P. (1991) Iron, free radicals and cancer. Med. Oncol. Tumor Pharmacother., 8, 229-233.
3. Stevens, R.G. and Kalkward, D.R. (1990) Iron, radiation and cancer. Env. Health Perspect., 87, 291-300.
4. Stevens, R.G., Beasley, R.P. and Blumberg, B.S. (1986) Iron-binding proteins and risk of cancer in Taiwan. J. Natl Cancer Inst., 76, 605-610.
5. Weinberg, E.D. (1991) Cellular iron metabolism in health and disease. Drug Metab. Rev., 22, 531-579.
6. Weinberg, E.D. (1984) Iron witholding: A defense against infection and neoplasia. Physiol. Rev., 64, 65-102.
7. Weinberg, E.D. (1992) Roles of iron in promotion, prevention and therapy. Biol. Trace Elem. Res., 34, 123-140.
8. Weinberg, E.D. (1981) Iron in neoplasia. Biol. Trace Elem. Res., 3, 55-80.
9. Selby, J.V. and Friedman, G.D. (1988) Epidemiologic evidence of an association between body iron stores and risk of cancer. Int. J. Cancer, 41, 677-682.
10. Stevens, R.G., Jones, Y., Micozzi, M.S. and Taylor, P.R. (1988) Body iron sores and the risk of cancer. New Engl. J. Med., 319, 1047-1052.
11. Weinberg, E.D. (1996) The role of iron in cancer. Eur. J. Cancer Prev., 5, 19-36.
12. Toyokuni, S. (1996) Iron-induced carcinogenesis: The role of redox regulation. Free Rad. Biol. Med., 20, 553-566.
13. Okada, S. (1996) Iron-induced tissue damage and cancer: The role of reactive oxygen species-free radicals. Path. Int., 46, 311-332.
14. Meneghini, R. (1997) Iron homeostasis, oxidative stress and DNA damage. Free Rad. Biol. Med., 23, 783-792.
15. Winterbourn, C.C. (1995) Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol. Lett., 82-83, 969-974.
16. McCord, J.M. (1998) Iron, free radicals and oxidative injury. Semin. Hematol., 35, 5-12.
17. McCord, J.M. (1996) Effects of positive iron status at a cellular level. Nutr. Rev., 54, 85-88.
18. Bisset, D.L., Chatterjee, R. and Hannon, D.P. (1990) Photoprotective effect of superoxide-scavenging antioxidants against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol. Photoimmunol. Photomed., 7, 56-62.
19. Black, H. and Chan, J.T. (1975) Suppression of ultraviolet light-induced tumor formation by dietary antioxidants. J. Invest. Dermatol., 65, 412-414.
20. Black, H., Chan, J.T. and Brown, G.E. (1978) Effects of dietary constituents on ultraviolet light-mediated carcinogenesis. Cancer Res., 38, 1384-1387.
21. Black, H., Lenger, W., McCann, V. and Thornby, J. (1983) Relation of UV dose to antioxidant modification of photocarcinogenesis. J. Am. Coll. Toxicol., 2, 201-207.
22. Gensler, H.L. and Magdaleno, M. (1991) Topical vitamin E inhibition of immunosuppression and tumorigenesis induced by ultraviolet radiation. Nutr. Cancer, 15, 97-106.
23. Gensler, H.L., Gerrish, K.E., Williams, T., Rao, G. and Kittelson, J. (1994) Prevention of photocarcinogenesis and UV-induced immunosuppression in mice by topical tannic acid. Nutr. Cancer, 22, 121-130.
24. Gerrish, K.E. and Gensler, H.L. (1993) Prevention of photocarcinogenesis by dietary vitamin E. Nutr. Cancer, 19, 125-133.
25. Wang, Z.Y., Agarwal, R., Bickers, D.R. and Mukhtar, H. (1991) Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis, 12, 1527-1530.
26. Wang, Z.Y., Huang, M.T., Ferraro, T., Wong, C.Q., Lou, Y.R., Iatropoulos, M., Yang, C.S. and Conney, A.H. (1992) Inhibitory effect of green tea in the drinking water on tumorigenesis by ultraviolet light and 12-O-tetradecanoylphorbol-13-acetate in the skin of SKH-1 mice. Cancer Res., 52, 1162-1170.
27. Wang, Z.Y., Huang, M.T., Lou, Y.R., Xie, J.G., Reuhl, K.R., Newmark, H., Ho, C.T., Yang, C.S. and Conney, A.H. (1994) Inhibitory effects of black tea, green tea, decaffeinated black tea and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]-anthracene-initiated SKH-1 mice. Cancer Res., 54, 3428-3435.
28. Morliere, P., Salmon, S., Aubailly, M., Risler, A. and Santus, R. (1997) Sensitization of skin fibroblasts to UVA by excess iron. Biochem. Biophys. Acta, 1334, 283-290.
29. Isoherranen, K., Westermarck, J., Kahari, V.M., Jansen, C. and Punnonen, K. (1998) Differential regulation of AP-1 family members by UV irradiation in vitro and in vivo. Cell. Sigalling, 10, 191-195.
30. Barthelman, M., Chen, W., Gensler, H.L., Huang, C., Dong, Z. and Bowden, G.T. (1998) Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res., 58, 711-716.
31. Huang, C., Ma, W.Y., Bowden, T. and Dong, Z. (1996) Ultraviolet B-induced activated protein-1 activation does not require epidermal growth factor receptor but is blocked by a dominant negative PKC λ/ι*. J. Biol. Chem., 271, 31262-31268.
32. Huang, C., Ma, W.Y., Hanenberger, D., Cleary, M.P., Bowden, G.T. and Dong, Z. (1997) Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J. Biol. Chem., 272, 26325-26331.
33. Fisher, G.J., Datta, S.C., Talwar, H.S., Wang, Z.Q., Varani, J., Kang, S. and Voorhees, J.J. (1996) Molecular basis of sun-induced premature skin ageing and retinoid metabolism. Nature, 379, 335-339.
34. Garmyn, M. and Degreef, H. (1999) Suppression of UVB-induced c-fos and c-jun expression in human keratinocytes by N-acetylcysteine. J. Photochem. Photobiol. Biol., 37, 125-130.
35. Dong, Z., Lavrovsky, V. and Colburn, N. (1995) Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis, 16, 749-756.
36. Li, J.J., Dong, Z., Dawson, M.I. and Colburn, N.H. (1996) Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res., 56, 483-489.
37. Dong, Z., Birrer, M.J., Watts, R.G., Matrisian, L. and Colburn, N. (1994) Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl Acad. Sci. USA, 91, 609-613.
38. Dong, Z., Huang, C., Brown, R.E. and Ma, W.Y. (1997) Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem., 272, 9962-9970.
39. Domann, F.E., Levy, J.P., Finch, J.S. and Bowden, G.T. (1994) Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog., 9, 61-66.
40. Yuspa, S.H. (1998) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis. J. Dermatol. Sci., 17, 1-7.
41. Domann, F.E., Levy, J.P., Birrer, M.J. and Bowden, G.T. (1994) Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ., 5, 9-16.
42. Dong, Z., Crawford, H.C., Lavrovsky, V., Taub, D., Watts, R.G., Matrisian, L. and Colburn, N. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinog., 19, 204-212.
43. Wu, M.L., Yang, C.C., Ger, J. and Deng, J.F. (1998) A fatal case of acute ferric chloride poisoning. Vet. Hum. Toxicol, 40, 31-34.
44. Kyriakou, D., Eliopoulis, A.G., Papadakis, A., Alexandrakis, M. and Eliopoulis, G.D. (1998) Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassaemia patients receiving desferrioxamine. Eur. J. Haematol., 60, 21-27.
45. Porter, J.B. (1997) A risk-benefit assessment of iron-chelation therapy. Drug Safety, 17, 407-421.
46. Jacob, A.K., Hotchkiss, R.S., DeMeester, S.L., Hiramatsu, M., Karl, I.E., Swanson, P.E., Cobb, J.P. and Buchman, T.G. (1997) Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery, 122, 243-253.
47. Kirking, M.H. (1991) Treatment of chronic iron overload. Clin. Pharm., 10, 775-783.
48. Double, K.L., Maywald, M., Schmittel, M., Rierder, P. and Gerlach, M. (1998) In vitro studies of ferritin iron release and neurotoxicity. J. Neurochem., 70, 2492-2499.
49. 1 phase of the cell cycle. Liver, 18, 60-66.
50. Rao, M.S. and Subbarao, V. (1997) The effect of deferoxamine on ciprofibrate-induced hepatocarcinogenesis in the rat. In Vivo, 11, 495-498.
51. Lan, J. and Jiang, D.H. (1997) Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice. J. Neural Transmiss., 104, 469-481.
52. Morris, S.F., Pang, C.Y., Lofchy, N.M., Davidson, G., Lindsay, W.K., Zuker, R.M. and Boyd, B. (1993) Deferoxamine attenuates ischemia-induced reperfusion injury in the skin and muscle of myocutaneous flaps in the pig. Plastic Reconstruct. Surg., 92, 120-132.
53. Soybir, G.R., Koyuncu, H., Koksoy, F., Yalcin, O., Ozseker, A., Alatli, C. and Topuzlu, C. (1996) Protective effect of desferrioxamine against TPA caused inflammation in CD-1 mouse skin. Surg. Oncol., 5, 253-258.
54. Shimmura, S., Suematsu, M., Shimoyama, M., Tsubota, K., Oguchi, Y. and Ishimura, Y. (1996) Subthreshold UV-radiation-induced peroxide formation in cultured corneal epithelial cells: The protective effects of lactoferrin. Exp. Eye Res., 63, 519-526.
55. Masaki, H. and Sakurai, H. (1997) Increased generation of hydrogen peroxide possibly from mitochondrial respiratory chain after UVB irradiation of murine fibroblasts. J. Derm. Sci., 14, 207-216.
56. Takeuchi, T., Nakajima, M. and Morimoto, K. (1996) Relationship between the intracellular reactive oxygen species and the induction of oxidative DNA damage in human neutrophil-like cells. Carcinogenesis, 17, 1543-1548.
57. Brenneisen, P., Wenk, J., Klotz, L.O., Wlaschek, M., Briviba, K., Krieg, T., Sies, H. and Scharffetter-Kochanek, K. (1998) Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloproteinase (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol. Chem., 273, 5279-5287.
58. Breuer, W., Greenberg, E. and Cabantchik, Z.I. (1997) Newly delivered transferrin iron and oxidative injury. FEBS Lett., 403, 213-219.
59. Rothman, R.J., Serroni, A. and Farber, J.A. (1992) Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury. Mol. Pharmacol., 42, 703-710.
60. Zhan, H., Gupta, R.K., Weaver, J. and Pollack, S. (1990) Iron bound to low MW ligands: Interactions with mitochondria and cytosolic proteins. Eur. J. Haematol., 44, 124-130.
61. Halliwell, B. and Gutteridge, J.M.C. (1990) Role of free radicals and catalytic metal ions in human diease: An overview. Methods Enzymol., 186, 1-85.
62. Hershko, C. (1988) Iron chelating therapy. CRC Crit. Rev. Clin. Lab. Sci., 26, 303-345.
63. Rouault, T.A. and Klausner, R.D. (1996) The impact of oxidative stress on eukaryotic iron metabolism. EXS, 77, 183-197.
64. Reif, D.W. (1992) Ferritin as a source of iron for oxidative damage. Free Rad. Biol. Med., 12, 417-427.
65. Abate, C., Patel, L., Rauscher, F.J. and Curran, T. (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science, 249, 1157-1161.
66. Amstad, P., Krupitza, G. and Cerruti, P.A. (1992) Mechanism of c-fos induction by active oxygen. Cancer Res., 52, 3952-3960.
67. Traber, M.G. and Packer, L. (1995) Vitamin E: Beyond antioxidant function. Am. J. Clin. Nutr., 62, 1501s-1509s.
68. 2. Role in cell survival following oxidant injury. J. Biol. Chem., 271, 4138-4142.
69. Liu, Y., Guyton, K.Z., Gorospe, M., Xu, Q., Lee, J.C. and Holbrook, N.J. (1996) Differential activation of ERK, JNK/SAPK and P38/CSBP/RK MAP kinase family members during the cellular response to arsenite. Free Rad. Biol. Med., 21, 771-781.
70. Wilmer, W.A., Tan, L.C., Dickerson, J.A., Danne, M. and Rovin, B.H. (1997) Interleukin-1 beta induction of mitogen-activated protein kinases in human mesangial cells. Role of oxidation. J. Biol. Chem., 272, 10877-10881.